Notice of Change to NOT-NS-21-014 "Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination"
Notice Number:
NOT-NS-22-106

Key Dates

Release Date:

May 31, 2022

Related Announcements

NOT-NS-21-014 - Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination

NOT-NS-22-082 - Notice of Change to Due Dates and Eligibility Criteria for NOT-NS-21-014, "Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination"

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to clarify the Eligibility Criteria for NOT-NS-21-014 "Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination". Changes to the NOSI are shown below:

Currently Reads:

Application and Submission Information

Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.

  • PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:

  • Submission acceptance is continuous but will be reviewed in cohorts based on time of submission:
    • Application Acceptance Periods March 15, 2021 to May 31, 2021, June 1, 2021 to August 31, 2021, September 1, 2021 to November 30, 2021, December 1, 2021 to February 28, 2022

      March 15, 2022 – May 31, 2022

      June 1, 2022 – August 31, 2022

      September 1, 2022 – November 30, 2022

      December 1, 2022 – February 28, 2023

    • Submissions are due by 5:00 PM local time of applicant organization.

  • For funding consideration, applicants must include “NOT-NS-21-014” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
  • Eligibility criteria
    • Only existing awardees of the BRAIN Initiative (including SBIR/STTR) are eligible to apply.
    • To apply for an administrative supplement award under this NOSI, applicants must have received a prior grant from the NIH BRAIN Initiative which must be active at the time of submission. The efforts proposed in the supplement applications may extend beyond the competitive segment of the active parent award by up to 12 months, if a request for a non-competing extension of the final budget period of the parent award’s project period is submitted to and approved by the appropriate grants management officer, in writing, prior to a supplement award being issued and at least 30 days prior to the end of the final budget period of the parent award. Otherwise, the project period of the supplement application will be prorated to end concurrent with that of the parent award. Grants currently under no-cost extension are ineligible.

Modified To Read:

Application and Submission Information

Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.

  • PA-20-272- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:

  • Submission acceptance is continuous but will be reviewed in cohorts based on time of submission:
    • Application Acceptance Periods March 15, 2021 to May 31, 2021, June 1, 2021 to August 31, 2021, September 1, 2021 to November 30, 2021, December 1, 2021 to February 28, 2022

      March 15, 2022 – May 31, 2022

      June 1, 2022 – August 31, 2022

      September 1, 2022 – November 30, 2022

      December 1, 2022 – February 28, 2023

    • Submissions are due by 5:00 PM local time of applicant organization.

  • For funding consideration, applicants must include “NOT-NS-21-014” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
  • Eligibility criteria
    • Only existing awardees of the BRAIN Initiative (including SBIR/STTR) are eligible to apply.
    • To apply for an administrative supplement award under this NOSI, applicants must have received a prior grant from the NIH BRAIN Initiative which must be active at the time of submission. The efforts proposed in the supplement applications may extend beyond the competitive segment of the active parent award by up to 12 months, if a request for a non-competing extension of the final budget period of the parent award’s project period has been submitted and approved by the appropriate grants management officer, in writing, prior to a supplement application being submitted and at least 30 days prior to the end of the final budget period of the parent award. Otherwise, the project period of the supplement application will be prorated to end concurrent with that of the parent award. Grants currently under no-cost extension are ineligible.

All other aspects of this NOSI remain unchanged.

Inquiries

Please direct all inquiries to:

Dr. Kari Ashmont
National Institute of Biomedical Imaging and Bioengineering (NIBIB) 
Email: (Kari.Ashmont@nih.gov)

Dr. Maryam Ghaleh
National Institute of Neurological Disorders and Stroke (NINDS)
Email: (maryam.ghaleh@nih.gov)